Peapack-Gladstone Financial Corp’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-91,221
Closed -$9.06M 371
2019
Q3
$9.06M Sell
91,221
-700
-0.8% -$66.5K 0.39% 76
2019
Q2
$8.5M Sell
91,921
-423
-0.5% -$40.2K 0.37% 80
2019
Q1
$8.71M Sell
92,344
-23,483
-20% -$2.05M 0.39% 78
2018
Q4
$7.42M Sell
115,827
-27,253
-19% -$2.01M 0.38% 79
2018
Q3
$12.8M Sell
143,080
-1,063
-0.7% -$93.9K 0.63% 57
2018
Q2
$11.4M Buy
144,143
+46,812
+48% +$3.89M 0.6% 58
2018
Q1
$8.68M Buy
97,331
+15,474
+19% +$1.49M 0.47% 71
2017
Q4
$8.54M Buy
81,857
+18,583
+29% +$2.1M 0.46% 73
2017
Q3
$9.23M Buy
63,274
+1,892
+3% +$258K 0.53% 68
2017
Q2
$7.97M Buy
61,382
+322
+0.5% +$39.5K 0.48% 67
2017
Q1
$7.6M Buy
61,060
+460
+0.8% +$55K 0.47% 72
2016
Q4
$7.01M Buy
60,600
+1,671
+3% +$186K 0.45% 73
2016
Q3
$6.16M Buy
58,929
+2,769
+5% +$300K 0.41% 78
2016
Q2
$5.54M Sell
56,160
-1,070
-2% -$111K 0.38% 82
2016
Q1
$5.73M Buy
57,230
+1,050
+2% +$108K 0.4% 79
2015
Q4
$6.73M Buy
56,180
+1,075
+2% +$124K 0.47% 69
2015
Q3
$5.96M Buy
55,105
+503
+0.9% +$62.4K 0.45% 74
2015
Q2
$6.32M Sell
54,602
-1,222
-2% -$140K 0.44% 75
2015
Q1
$6.44M Sell
55,824
-2,175
-4% -$260K 0.44% 72
2014
Q4
$6.49M Buy
57,999
+7,281
+14% +$768K 0.46% 71
2014
Q3
$4.81M Hold
50,718
0.36% 83
2014
Q2
$4.36M Buy
50,718
+11,572
+30% +$880K 0.33% 86
2014
Q1
$2.73M Buy
39,146
+18,614
+91% +$1.47M 0.22% 107
2013
Q4
$1.73M Buy
20,532
+9,440
+85% +$747K 0.14% 126
2013
Q3
$855K Buy
11,092
+500
+5% +$35K 0.08% 156
2013
Q2
$620K Buy
+10,592
New +$637K 0.06% 177

Other funds holding CELG

Peapack-Gladstone Financial Corp's CELG Position: Q4 2019 in Review

Peapack-Gladstone Financial Corp sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 91,221 shares — an estimated $9.06M sold.

Peapack-Gladstone Financial Corp first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $12.8M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Peapack-Gladstone Financial Corp reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 91,221 Celgene Corp shares in Q4 2019, an estimated $9.06M.
  • Peapack-Gladstone Financial Corp first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Peapack-Gladstone Financial Corp's Celgene Corp position peaked at $12.8M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q4 2019, filed 14 Feb 2020.